VDAC1 and neoplasm: Our research showed that targeting VDAC1 with si-VDAC1 led to reprogramming of cancer metabolism, which in turn reduced tumor growth and invasiveness, inhibited angiogenesis, eliminated CSCs, and promoted tumor cell differentiation [74].